Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

Serenic

From Wikipedia, the free encyclopedia
(Redirected fromAntiaggressive)
Type of drug that reduces aggression
Serenic
Drug class
Class identifiers
SynonymsAnti-aggressive drug; Anti-aggressive agent; Anti-aggressive medication; Antiaggressive drug; Antiaggressive agent; Antiaggressive medication
UseTo reduceaggression andanger
Legal status
In Wikidata

Aserenic, oranti-aggressive drug, is a type ofdrug which reduces the capacity foraggression.[1] Known drugs with antiaggressive effects include variousserotonergic agents,antidopaminergic drugs likeantipsychotics,anticonvulsants andmood stabilizers,beta blockers,nicotine,cannabinoids,oxytocin- andvasopressin-related drugs, andtestosterone-suppressing drugs.

Examples

[edit]

Serotonergic agents

[edit]

The recreational drugMDMA ("ecstasy") and a variety of related drugs have been described asempathogen-entactogens, or simply asentactogens.[2] These agents possess serenic andempathy-increasing properties in addition to theireuphoriant effects, and have been associated with increased sociability, friendliness, and feelings of closeness to others as well asemotional empathy andprosocial behavior.[3][4] The entactogenic effects of these drugs are thought to be related to their ability to temporarily increase the levels of certain brain chemicals, includingserotonin,[5]dopamine, and, particularly,oxytocin.[3][6][7]

Certain otherserotonergic drugs, such as5-HT1A receptor agonists, also increase oxytocin levels and may possess serenic properties as well.[8] Thephenylpiperazine mixed 5-HT1A and5-HT1B receptor agonistseltoprazine,fluprazine, andbatoprazine have been described based onanimal research as serenics.[9] The selective 5-HT1Abiasedfull agonistF-15,599 (NLX-101) has shown antiaggressive effects in rodents as well.[10]

The serotonin5-HT2C receptor agonistlorcaserin has been found to reduce impulsive aggression in people withintermittent explosive disorder (IED).[11][12][13][14] Serotonin 5-HT2C receptor agonists have also been found to produce antiaggressive effects in rodents.[11]

Theserotonergic psychedelicsDOB andDOI, which act as serotonin5-HT2 receptor agonists, show antiaggressive effects in rodents.[11][15][16][17] However, DOI has also been found to have pro-aggressive effects.[11] In older literature, other psychedelics, includingLSD,psilocin,dimethyltryptamine (DMT), andmescaline, have been found to reduce aggression in monkeys, but have also been found to increase aggression in animals in other contexts.[18] Serotonin5-HT2A receptor antagonists have been found to reduce aggression in animals.[11]Atypical antipsychotics, which act in part as serotonin 5-HT2A receptor antagonists, have antiaggressive effects in humans.[11]Theselective serotonin reuptake inhibitors (SSRIs)sertraline,fluvoxamine, andfluoxetine inhibited aggression in rodents, whereas the SSRIscitalopram andparoxetine were ineffective.[19][20]

Antidopaminergic agents

[edit]

Antipsychotics, which aredopamineD2 receptorantagonists, are well-known as reducing aggression in humans and have been clinically employed for this purpose.[21]Molindone is under development for the treatment ofimpulsive aggression in children and adolescents withattention deficit hyperactivity disorder (ADHD).[22][23]

Anticonvulsants and mood stabilizers

[edit]

Certainanticonvulsants andmood stabilizers, includingvalproic acid/divalproex sodium,carbamazepine,oxcarbazepine,phenytoin,lamotrigine,topiramate, andlithium, have been found to be effective in the treatment ofaggression.[24][25][26][27][28] Certain others, includinggabapentin andtiagabine, may also have antiaggressive effects.[24][26][28] Conversely,levetiracetam has been found to be ineffective.[24][28] Although anticonvulsants have been found to be effective for treating aggression, it has been reported that many of the same drugs might also produceanger, aggression, andirritability in people withepilepsy.[29][30]

Beta blockers

[edit]

Beta blockers, orβ-adrenergic receptorantagonists, have been used to treataggression andagitation.[31] Beta blockers that have been used for such purposes includepropranolol,pindolol, andnadolol.[31]

Psychostimulants

[edit]

Psychostimulants likemethylphenidate andamphetamines as well as theatypical antipsychotic risperidone are useful in reducing aggression andoppositionality in children and adolescents withattention-deficit hyperactivity disorder (ADHD),antisocial personality disorder, andautism spectrum disorder with moderate to largeeffect sizes and greater effectiveness than other studied medications.[32][33] Another meta-analysis found that methylphenidate slightly reducedirritability while amphetamines increased the risk of irritability several-fold in children with ADHD however.[34] Other research has found no impact ofamphetamine ormethamphetamine on aggression in humans.[35]

Cholinergic agents

[edit]

Nicotinic acetylcholine receptors within the CNS, specificallyα7 homopentameric receptors, are implicated in the regulation of aggression. The serenic effect of nicotine is well documented both in laboratory animals and humans, and, conversely,nicotinic receptor antagonists and nicotine withdrawal are associated with irritability and aggression.[36][37][38] Additionally, nicotinic receptors are required forrabies virus entry into a neuron, and the dysfunction of these neurons is implicated in the rabies-associated aggression.[39]

Cannabinoids

[edit]

Cannabinoids likenabilone have been studied and reported effective for management of severe aggression in people with profoundautism and otherintellectual anddevelopmental disabilities.[40]

Hormonal and related agents

[edit]

Agonists andantagonists of thereceptors for theendogenoushormonesoxytocin andvasopressin, respectively, have been shown to decrease aggressive behavior in scientific research, implicating them in the normal regulation of pathways involving aggressive behavior in the brain.[41][42]Small-moleculeoxytocin-like drugs likeKNX-100 have been found to produce antiaggressive effects in animals.[43] Certainneurosteroids, such asallopregnanolone, also appear to play a role in the regulation of aggression, including, notably,sexually-dimorphic aggressive behavior.[44] Thesex hormonestestosterone andestradiol regulate aggression as well.[45][46][47]

See also

[edit]

References

[edit]
  1. ^Olivier B, Mos J (10 July 1986). Chan DK (ed.)."Serenics and aggression".Stress & Health.2 (3).Arlington,Virginia,United States of America:Wiley:197–209.doi:10.1002/smi.2460020305.ISSN 1532-2998.
  2. ^Bedi G, Hyman D, de Wit H (December 2010). Krystal JH (ed.)."Is ecstasy an "empathogen"? Effects of ±3,4-methylenedioxymethamphetamine on prosocial feelings and identification of emotional states in others".Biological Psychiatry.68 (12).Brentwood,Tennessee, United States of America: Society of Biological Psychiatry:1134–1140.doi:10.1016/j.biopsych.2010.08.003.LCCN 78009779.OCLC 424038458.PMC 2997873.PMID 20947066.
  3. ^abHysek CM, Schmid Y, Simmler LD, Domes G, Heinrichs M, Eisenegger C, et al. (November 2014). Lieberman MD (ed.)."MDMA enhances emotional empathy and prosocial behavior".Social Cognitive and Affective Neuroscience.9 (11).Oxford University Press:1645–1652.doi:10.1093/scan/nst161.PMC 4221206.PMID 24097374.
  4. ^Cami J, Farré M, Mas M, Roset PN, Poudevida S, Mas A, et al. (August 2000). "Human pharmacology of 3,4-methylenedioxymethamphetamine ("ecstasy"): psychomotor performance and subjective effects".Journal of Clinical Psychopharmacology.20 (4):455–466.doi:10.1097/00004714-200008000-00010.PMID 10917407.
  5. ^Piper BJ, Fraiman JB, Owens CB, Ali SF, Meyer JS (April 2008). Carlezon WA, George TP, Neumaier JF (eds.)."Dissociation of the neurochemical and behavioral toxicology of MDMA ('Ecstasy') by citalopram".Neuropsychopharmacology.33 (5).Brentwood,Tennessee, United States of America:American College of Neuropsychopharmacology (ACNP):1192–1205.doi:10.1038/sj.npp.1301491.PMID 17609680.
  6. ^Dumont GJ, Sweep FC, van der Steen R, Hermsen R, Donders AR, Touw DJ, et al. (2009). Eslinger P, Boggio PS, Young L, Zahn R (eds.). "Increased oxytocin concentrations and prosocial feelings in humans after ecstasy (3,4-methylenedioxymethamphetamine) administration".Social Neuroscience.4 (4).London, United Kingdom of Great Britain: Society for Social Neuroscience/Taylor & Francis:359–366.doi:10.1080/17470910802649470.LCCN 2006244001.OCLC 69984013.PMID 19562632.S2CID 12310995.
  7. ^Broadbear JH, Kabel D, Tracy L, Mak P (April 2014). Koob JF, Schulteis G, Kantak KM, Arends M, Buisman-Pijlman FT, Broadbear JH, Zoltán S (eds.). "Oxytocinergic regulation of endogenous as well as drug-induced mood".Pharmacology, Biochemistry, and Behavior.119 (1).Amsterdam, Netherlands:Elsevier:61–71.doi:10.1016/j.pbb.2013.07.002.LCCN 73644949.OCLC 1787728.PMID 23872370.S2CID 19772247.
  8. ^de Boer SF, Koolhaas JM (December 2005). Redegeld FA, Verri WA, Burk J (eds.). "5-HT1A and 5-HT1B receptor agonists and aggression: a pharmacological challenge of the serotonin deficiency hypothesis".European Journal of Pharmacology.526 (1–3).Amsterdam, Netherlands:Elsevier:125–139.doi:10.1016/j.ejphar.2005.09.065.LCCN sf97001017.OCLC 01568459.PMID 16310183.
  9. ^Olivier B (December 2004). "Serotonin and aggression".Annals of the New York Academy of Sciences.1036 (1).New York City,New York, United States of America:New York Academy of Sciences:382–392.Bibcode:2004NYASA1036..382O.doi:10.1196/annals.1330.022.LCCN 12037287.OCLC 01306678.PMID 15817750.S2CID 45595253.
  10. ^Sałaciak K, Pytka K (November 2021)."Biased agonism in drug discovery: Is there a future for biased 5-HT1A receptor agonists in the treatment of neuropsychiatric diseases?".Pharmacol Ther.227 107872.doi:10.1016/j.pharmthera.2021.107872.PMID 33905796.
  11. ^abcdefPopova NK, Tsybko AS, Naumenko VS (August 2022)."The Implication of 5-HT Receptor Family Members in Aggression, Depression and Suicide: Similarity and Difference".Int J Mol Sci.23 (15): 8814.doi:10.3390/ijms23158814.PMC 9369404.PMID 35955946.There are some pharmacological data indicating a link between aggressive behavior and 5-HT2A receptor activity. In animals, 5-HT2A agonists, such as DOI, reduced aggressive behavior in flies, amphibians, mice and rats [34]. However, accumulated data also revealed a pro-aggressive effect of the 5-HT2A agonist DOI [119,120], whereas 5-HT2A antagonists effectively suppressed aggressive behavior [119,121,122]. In humans, a number of atypical antipsychotics, which act as antagonists of 5-HT2A receptors, had antiaggressive effects in clinical trials reviewed by Comai and co-authors [123]. [...] There are a few currently available data in support of the antiaggressive role of 5-HT2C receptors: (1) the activation of 5-HT2C receptors enhanced the display of defeat submissive and defensive behavior in golden hamsters [172]. (2) 5-HT2C receptor agonist/alpha 2 receptor antagonist S32212 suppressed aggressive behavior in mice [173]. (3) Mice expressing only the VGV isoform of 5-HT2C receptors displayed a high level of conspecific aggression [174]. (4) The association between Htr2c gene polymorphism and criminal behavior in humans was demonstrated [175]. (5) Recently, a novel 5-HT2C agonist, lorcaserin, has been demonstrated to have antiaggressive properties in human subjects with impulsive aggressive behavior. Lorcaserin attenuated provoked, but not unprovoked, aggression in impulsively aggressive individuals indicating that 5-HT2C receptor may be a putative target for the treatment of impulsive aggressive behavior in human subjects [176].
  12. ^Desilva, Nilifa; Hollander, Eric (2023). "Impulse Control Disorders: Intermittent Explosive Disorder, Kleptomania, Pyromania".Tasman's Psychiatry. Cham: Springer International Publishing. p. 1–49.doi:10.1007/978-3-030-42825-9_165-1.ISBN 978-3-030-42825-9.Based on evidence from a recent pilot study, lorcaserin, a selective 5-HT2c agonist, was found to have anti-aggressive effects in humans with high levels of impulsive aggression like in those diagnosed with IED.
  13. ^Tahir T, Wong MM, Maaz M, Naufal R, Tahir R, Naidoo Y (May 2022). "Pharmacotherapy of impulse control disorders: A systematic review".Psychiatry Res.311 114499.doi:10.1016/j.psychres.2022.114499.PMID 35305343.
  14. ^Coccaro EF, Lee RJ (November 2019). "5-HT2c agonist, lorcaserin, reduces aggressive responding in intermittent explosive disorder: A pilot study".Hum Psychopharmacol.34 (6) e2714.doi:10.1002/hup.2714.PMID 31774584.
  15. ^Morrison TR, Melloni RH (2014). "The role of serotonin, vasopressin, and serotonin/vasopressin interactions in aggressive behavior".Neuroscience of Aggression. Curr Top Behav Neurosci. Vol. 17. pp. 189–228.doi:10.1007/7854_2014_283.ISBN 978-3-662-44280-7.PMID 24496652.Another 5HT2A receptor partial agonist, DOB, has a marginally higher affinity for the 5HT2A receptor (in its low affinity state) than DOI (Roth et al. 1997), and in the water competition (WC) test it has been shown to block defensive aggression in rats. Interestingly, DOI also reduced the number of offensive aggressive behaviors (i.e., attacks, greater latency to first attack, shorter attack duration) in the same animals that exhibited DOI-induced reductions in defensive behaviors during the WC test (Muehlenkamp et al. 1995).
  16. ^Muehlenkamp F, Lucion A, Vogel WH (April 1995). "Effects of selective serotonergic agonists on aggressive behavior in rats".Pharmacology Biochemistry and Behavior.50 (4):671–674.doi:10.1016/0091-3057(95)00351-7.PMID 7617717.S2CID 12774131.
  17. ^Sakaue M, Ago Y, Sowa C, Sakamoto Y, Nishihara B, Koyama Y, Baba A, Matsuda T (May 2002)."Modulation by 5-hT2A receptors of aggressive behavior in isolated mice".Jpn J Pharmacol.89 (1):89–92.doi:10.1254/jjp.89.89.PMID 12083749.
  18. ^Martin, W. R.; Sloan, J. W. (1977)."Pharmacology and Classification of LSD-like Hallucinogens".Drug Addiction II: Amphetamine, Psychotogen, and Marihuana Dependence. Berlin, Heidelberg: Springer Berlin Heidelberg. pp. 305–368.doi:10.1007/978-3-642-66709-1_3.ISBN 978-3-642-66711-4.
  19. ^Miczek KA, Fish EW, De Bold JF, De Almeida RM (October 2002). "Social and neural determinants of aggressive behavior: pharmacotherapeutic targets at serotonin, dopamine and gamma-aminobutyric acid systems".Psychopharmacology (Berl).163 (3–4):434–458.doi:10.1007/s00213-002-1139-6.PMID 12373445.
  20. ^Sánchez C, Meier E (February 1997). "Behavioral profiles of SSRIs in animal models of depression, anxiety and aggression. Are they all alike?".Psychopharmacology (Berl).129 (3):197–205.doi:10.1007/s002130050181.PMID 9084057.
  21. ^Itil TM, Wadud A (February 1975). "Treatment of human aggression with major tranquilizers, antidepressants, and newer psychotropic drugs".J Nerv Ment Dis.160 (2–1):83–99.doi:10.1097/00005053-197502000-00003.PMID 235010.
  22. ^"Molindone - Supernus Pharmaceuticals".AdisInsight. 29 May 2024. Retrieved18 October 2024.
  23. ^Robb AS, Schwabe S, Ceresoli-Borroni G, Nasser A, Yu C, Marcus R, Candler SA, Findling RL (March 2019)."A proposed anti-maladaptive aggression agent classification: improving our approach to treating impulsive aggression".Postgrad Med.131 (2):129–137.doi:10.1080/00325481.2019.1574401.PMID 30678534.
  24. ^abcStanford MS, Anderson NE, Lake SL, Baldridge RM (September 2009). "Pharmacologic treatment of impulsive aggression with antiepileptic drugs".Curr Treat Options Neurol.11 (5):383–390.doi:10.1007/s11940-009-0043-3.PMID 19744405.
  25. ^Huband N, Ferriter M, Nathan R, Jones H (February 2010)."Antiepileptics for aggression and associated impulsivity".Cochrane Database Syst Rev.2010 (2) CD003499.doi:10.1002/14651858.CD003499.pub3.PMC 4163499.PMID 20166067.
  26. ^abComai S, Tau M, Pavlovic Z, Gobbi G (April 2012). "The psychopharmacology of aggressive behavior: a translational approach: part 2: clinical studies using atypical antipsychotics, anticonvulsants, and lithium".J Clin Psychopharmacol.32 (2):237–260.doi:10.1097/JCP.0b013e31824929d6.PMID 22367663.
  27. ^Guay DR (December 2007). "Newer antiepileptic drugs in the management of agitation/aggression in patients with dementia or developmental disability".Consult Pharm.22 (12):1004–1034.doi:10.4140/tcp.n.2007.1004.PMID 18198960.
  28. ^abcGallagher D, Herrmann N (October 2014). "Antiepileptic drugs for the treatment of agitation and aggression in dementia: do they have a place in therapy?".Drugs.74 (15):1747–1755.doi:10.1007/s40265-014-0293-6.PMID 25239267.
  29. ^Brodie MJ, Besag F, Ettinger AB, Mula M, Gobbi G, Comai S, Aldenkamp AP, Steinhoff BJ (July 2016)."Epilepsy, Antiepileptic Drugs, and Aggression: An Evidence-Based Review".Pharmacol Rev.68 (3):563–602.doi:10.1124/pr.115.012021.PMC 4931873.PMID 27255267.
  30. ^Hansen CC, Ljung H, Brodtkorb E, Reimers A (2018)."Mechanisms Underlying Aggressive Behavior Induced by Antiepileptic Drugs: Focus on Topiramate, Levetiracetam, and Perampanel".Behav Neurol.2018 2064027.doi:10.1155/2018/2064027.PMC 6276511.PMID 30581496.
  31. ^abBoyce TG, Ballone NT, Certa KM, Becker MA (2021). "The Use of β-Adrenergic Receptor Antagonists in Psychiatry: A Review".J Acad Consult Liaison Psychiatry.62 (4):404–412.doi:10.1016/j.jaclp.2020.12.009.PMID 34210401.
  32. ^Pringsheim T, Hirsch L, Gardner D, Gorman DA (February 2015)."The pharmacological management of oppositional behaviour, conduct problems, and aggression in children and adolescents with attention-deficit hyperactivity disorder, oppositional defiant disorder, and conduct disorder: a systematic review and meta-analysis. Part 1: psychostimulants, alpha-2 agonists, and atomoxetine".Can J Psychiatry.60 (2):42–51.doi:10.1177/070674371506000202.PMC 4344946.PMID 25886655.
  33. ^Pringsheim T, Hirsch L, Gardner D, Gorman DA (February 2015)."The pharmacological management of oppositional behaviour, conduct problems, and aggression in children and adolescents with attention-deficit hyperactivity disorder, oppositional defiant disorder, and conduct disorder: a systematic review and meta-analysis. Part 2: antipsychotics and traditional mood stabilizers".Can J Psychiatry.60 (2):52–61.doi:10.1177/070674371506000203.PMC 4344947.PMID 25886656.
  34. ^Stuckelman ZD, Mulqueen JM, Ferracioli-Oda E, Cohen SC, Coughlin CG, Leckman JF, Bloch MH (June 2017). "Risk of Irritability With Psychostimulant Treatment in Children With ADHD: A Meta-Analysis".J Clin Psychiatry.78 (6):e648–e655.doi:10.4088/JCP.15r10601.PMID 28682529.
  35. ^O'Malley KY, Hart CL, Casey S, Downey LA (October 2022). "Methamphetamine, amphetamine, and aggression in humans: A systematic review of drug administration studies".Neurosci Biobehav Rev.141 104805.doi:10.1016/j.neubiorev.2022.104805.hdl:10072/422156.PMID 35926727.
  36. ^Lewis AS, Picciotto MR (May 2020)."Regulation of aggressive behaviors by nicotinic acetylcholine receptors: Animal models, human genetics, and clinical studies".Neuropharmacology.167 107929.doi:10.1016/j.neuropharm.2019.107929.PMC 7080580.PMID 32058178.
  37. ^Lewis AS, Mineur YS, Smith PH, Cahuzac EL, Picciotto MR (October 2015)."Modulation of aggressive behavior in mice by nicotinic receptor subtypes".Biochemical Pharmacology. Nicotinic Acetylcholine Receptors as Therapeutic Targets: Emerging Frontiers in Basic Research and Clinical Science (Satellite to the 2015 Meeting of the Society for Neuroscience) Oct 14-15, Chicago, IL USA.97 (4):488–497.doi:10.1016/j.bcp.2015.07.019.PMC 4600457.PMID 26212554.
  38. ^Picciotto MR, Lewis AS, van Schalkwyk GI, Mineur YS (September 2015)."Mood and anxiety regulation by nicotinic acetylcholine receptors: A potential pathway to modulate aggression and related behavioral states".Neuropharmacology. The Nicotinic Acetylcholine Receptor: From Molecular Biology to Cognition.96 (Pt B):235–243.doi:10.1016/j.neuropharm.2014.12.028.PMC 4486625.PMID 25582289.
  39. ^Hueffer K, Khatri S, Rideout S, Harris MB, Papke RL, Stokes C, Schulte MK (October 2017)."Rabies virus modifies host behaviour through a snake-toxin like region of its glycoprotein that inhibits neurotransmitter receptors in the CNS".Scientific Reports.7 (1) 12818.Bibcode:2017NatSR...712818H.doi:10.1038/s41598-017-12726-4.PMC 5634495.PMID 28993633.
  40. ^Lin, Hsiang-Yuan; Abi-Jaoude, Elia; Desarkar, Pushpal; Wang, Wei; Ameis, Stephanie H.; Lai, Meng-Chuan; Lunsky, Yona; Rajji, Tarek (2025)."364. Nabilone for Severe Aggression in Adults With Profound Autism or Intellectual and Developmental Disabilities: A Phase I Open-Label Clinical Trial".Biological Psychiatry.97 (9): S246.doi:10.1016/j.biopsych.2025.02.602. Retrieved6 May 2025.
  41. ^Calcagnoli F, de Boer SF, Althaus M, den Boer JA, Koolhaas JM (October 2013). de Witt H, Curran VH, Morrow AL, Hashimoto K, Howes O, Floresco SB, D'Souza D (eds.)."Antiaggressive activity of central oxytocin in male rats".Psychopharmacology.229 (4).Geneva, Switzerland: European Behavioural Pharmacology Society (EBPS)/Springer:639–651.doi:10.1007/s00213-013-3124-7.PMID 23624810.S2CID 481042.
  42. ^Ferris CF, Lu SF, Messenger T, Guillon CD, Heindel N, Miller M, et al. (February 2006). Griebel G, Arends MA, Izenwasser S (eds.). "Orally active vasopressin V1a receptor antagonist, SRX251, selectively blocks aggressive behavior".Pharmacology, Biochemistry, and Behavior.83 (2).Amsterdam, Netherlands:169–174.doi:10.1016/j.pbb.2006.01.001.OCLC 67271683.PMID 16504276.S2CID 24199104.
  43. ^Salthouse T, Assereh N, Lee T, Wilson B, Tan O, Badolato C, Freeborn C, Bowen M (18 August 2025)."696. Whole Brain Activity Mapping of the Effects of a Novel Small Molecule on Chronic Social Isolation Induced Aggression in Mice".International Journal of Neuropsychopharmacology.28 (Supplement_2):ii56–ii57.doi:10.1093/ijnp/pyaf052.113.ISSN 1461-1457.PMC 12359352.KNX100 is a novel, prosocial compound that has been shown to reduce aggression in preclinical models. [...]
  44. ^Pinna G, Agis-Balboa RC, Pibiri F, Nelson M, Guidotti A, Costa E (October 2008). Schousboe A (ed.). "Neurosteroid biosynthesis regulates sexually dimorphic fear and aggressive behavior in mice".Neurochemical Research.33 (10).Geneva, Switzerland:Springer:1990–2007.doi:10.1007/s11064-008-9718-5.PMID 18473173.S2CID 19338424.
  45. ^Cunningham RL, Lumia AR, McGinnis MY (2012)."Androgen receptors, sex behavior, and aggression".Neuroendocrinology.96 (2):131–140.doi:10.1159/000337663.PMC 3474193.PMID 22414851.
  46. ^Giammanco M, Tabacchi G, Giammanco S, Di Majo D, La Guardia M (April 2005). "Testosterone and aggressiveness".Med Sci Monit.11 (4): RA136–45.PMID 15795710.
  47. ^Albert DJ, Jonik RH, Walsh ML (1992). "Hormone-dependent aggression in male and female rats: experiential, hormonal, and neural foundations".Neurosci Biobehav Rev.16 (2):177–192.doi:10.1016/s0149-7634(05)80179-4.PMID 1630729.
Major chemical drug groups – based upon theAnatomical Therapeutic Chemical Classification System
gastrointestinal tract
/metabolism (A)
blood and blood
forming organs (B)
cardiovascular
system
(C)
skin (D)
genitourinary
system
(G)
endocrine
system
(H)
infections and
infestations (J,P,QI)
malignant disease
(L01–L02)
immune disease
(L03–L04)
muscles,bones,
andjoints (M)
brain and
nervous system (N)
respiratory
system
(R)
sensory organs (S)
otherATC (V)
Retrieved from "https://en.wikipedia.org/w/index.php?title=Serenic&oldid=1336440915"
Category:
Hidden categories:

[8]ページ先頭

©2009-2026 Movatter.jp